News
-
Read more: Heidelberg Epignostix appoints Helge Lubenow as CEOHeidelberg, Germany, July 16, 2024 – Heidelberg Epignostix, a deeptech start-up committed to precision cancer diagnostics today announces the appointment of Helge Lubenow as CEO. She will be succeeding founder David Jones in the role who will continue to support Heidelberg Epignostix as Chief Scientific Officer. Helge Lubenow has almost 25 […]
-
DKFZ spin-off Epignostix raises €4.3m seed round to commercialize diagnostic tumor classifier
Posted by
–
Read more: DKFZ spin-off Epignostix raises €4.3m seed round to commercialize diagnostic tumor classifierHeidelberg, Germany, July 2, 2024 – Heidelberg Epignostix GmbH, a deeptech start-up committed to precision cancer diagnostics today announces €4.3M in seed funding. This investment will enable Heidelberg Epignostix to make a substantial leap forward in driving market development for its flagship indication for brain tumor classification. CARMA FUND I Capital GmbH […]
-
Heidelberg Epignostix is live!
Posted by
–
Read more: Heidelberg Epignostix is live!Heidelberg, November 2023 – We are thrilled to announce the arrival of Heidelberg Epignostix GmbH, a pioneering force in molecular neuropathology, with a mission to revolutionize cancer diagnostics by applying AI-based approaches for epigenetic tumor classification. Based on an exclusive license to IP from the world-renowned German Cancer Research Center […]
